+44 (0) 1223 755950
+1 832 327 7413
CCAAT/Enhancer Binding Protein Beta (CEBPB) Antibody
REQUEST MORE INFO
Catalogue No: abx011895
Price:
US$420.50
(Size: 100 µl)
Reviews: 
(0 Publications and Reviews)
(0 Publications and Reviews)
Click on the image to see the image legend
The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related proteins CEBP alpha, CEBP delta, and CEBP gamma. The encoded protein is important in the regulation of genes involved in immune and inflammatory responses and has been shown to bind to the IL-1 response element in the IL-6 gene, as well as to regulatory regions of several acute-phase and cytokine genes. In addition, the encoded protein can bind the promoter and upstream element and stimulate the expression of the collagen type I gene.
Research Articles on CCAAT/Enhancer Binding Protein Beta (CEBPB)
| Target | CCAAT/Enhancer Binding Protein Beta (CEBPB) |
| Clonality | Monoclonal |
| Reactivity | Human |
| Tested Applications | ELISA, FCM |
| Host | Mouse |
| Recommended dilutions | ELISA: 1/10000, FCM: 1/200 - 1/400. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant fragment of human CEBPB expressed in E. coli. |
| Isotype | IgG1 |
| Form | Liquid |
| Purification | Unpurified ascites. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| UniProt Primary AC | P17676 (UniProt, ExPASy) |
| UniProt Secondary AC | A8K671, Q96IH2, Q9H4Z5 |
| UniProt Entry Name | CEBPB_HUMAN |
| Gene Symbol | CEBPB |
| GeneID | 1051 |
| OMIM | 189965 |
| HGNC | 1834 |
| KEGG | hsa:1051 |
| Ensembl | ENSG00000172216 |
| String | 9606.ENSP00000305422 |
| Molecular Weight | 36 kDa |
| Buffer | Ascitic fluid containing 0.03% sodium azide. |
| Concentration | Not determined. |
| Availability | Shipped within 5-10 working days. |
| Note | This product is for research use only. |